06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />

cough and cold prep a ra tions 33%<br />

anti rheu ma tics top i cal 24%<br />

an ti his ta mines sys temic 8%<br />

renin-an gio ten sin sys tem agents 7%<br />

an ti bi ot ics, sulphonamides and antivirals top i cal<br />

6%<br />

Lead ing Dose Forms:<br />

tab lets 27%<br />

gels/sols 24%<br />

pow ders/gran ules 19%<br />

coated tab lets 9%<br />

cap sules 8%<br />

NOVARTIS<br />

Full Name: Novartis Pharma Ser vices AG<br />

Street Ad dress: 29, Bereznyakovskaya St.,<br />

02098 Kiev<br />

Tel: +380 44 490 53 38<br />

Fax: +380 44 490 53 39<br />

De scrip tion: Rep re sen ta tive of fice.<br />

Con tacts (Pharm): Chair man: Irina Karakai;<br />

Gen eral Con tact: Irina Karakai<br />

NOVARTIS CON SUMER HEALTH<br />

Full Name: Novartis Con sumer Health Ser vices<br />

SA<br />

Street Ad dress: Beriaznyakovskaya St. 29, 7th<br />

floor, 02098 Kiev<br />

Tel: +380 44 496 09 50<br />

Fax: +380 44 496 09 51<br />

Phar ma ceu ti cal Sales: US$ 18-20 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 65-70%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 90-95%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

90-95%<br />

Prin ci pal Prod ucts:<br />

VIBROCIL (na sal prep a ra tion top i cal)<br />

TERAFLU (cold prep a ra tion with out anti-in fec tive)<br />

LAMISIL (dermatological antifungal)<br />

OTRIVIN (na sal prep a ra tion top i cal)<br />

FENISTIL (antipruritic; an ti his ta mine sys temic)<br />

Ther a peu tic Range:<br />

na sal prep a ra tions 33%<br />

cough and cold prep a ra tions 31%<br />

dermatological antifungals 16%<br />

an ti his ta mines sys temic 7%<br />

anti rheu ma tics top i cal 5%<br />

Lead ing Dose Forms:<br />

liq uids 40%<br />

pow ders/gran ules 25%<br />

gels/sols 14%<br />

creams 10%<br />

pres sur ised aero sols 3%<br />

SANDOZ<br />

Full Name: Sandoz Rep re sen ta tive Of fice<br />

Ukraine<br />

Street Ad dress: Polevaya Street, 4 fl. 24d,<br />

03056 Kiev<br />

Tel: +380 44 495 28 66/29 41<br />

Fax: +380 44 495 29 43<br />

Home Page: www.sandoz.com<br />

De scrip tion: Rep re sen ta tive of fice. Pro moter.<br />

Prod uct ranges in clude: phar ma ceu ti cal prod ucts<br />

(branded, unbranded, pre scrip tion, non-pre scrip -<br />

tion), hos pi tal pharmaceuticals, raw ma te ri als, bi -<br />

o log i cal prod ucts, bio tech nol ogy prod ucts,<br />

di etetic/nu tri tional prod ucts, herbal prod ucts,<br />

vet er i nary pharmaceuticals. Es tab lished 1993.<br />

c.300 pharmaceutical employees in 2008.<br />

Rep re sen ta tives/De tail ers (Pharm, Num -<br />

ber): 180 (2008)<br />

Con tacts (Pharm): Chair man: Dr Ray Masch;<br />

Gen eral Con tact: Dr Ray Masch<br />

Phar ma ceu ti cal Sales: US$ 30-35 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 50-55%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 65-70%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

80-85%<br />

Prin ci pal Prod ucts:<br />

LINEX (antidiarrheal mi cro-or gan ism)<br />

PERSEN (hyp notic/sed a tive)<br />

OSPAMOX (pen i cil lin broad spec trum)<br />

BRONCHO MUNAL (vac cine other)<br />

AMOKSIKLAV 2X (pen i cil lin broad spec trum)<br />

Ther a peu tic Range:<br />

antibacterials sys temic 23%<br />

antidiarrheals, elec tro lyte re plac ers, in tes ti nal<br />

anti-inflammatorie s 17%<br />

psycholeptics 14%<br />

vac cines 8%<br />

urologicals 7%<br />

Lead ing Dose Forms:<br />

cap sules 35%<br />

coated tab lets 27%<br />

tab lets 8%<br />

liq uids 7%<br />

am poules 6%<br />

UNITED ARAB EMIRATES<br />

NOVARTIS<br />

Full Name: Novartis Pharma Ser vices AG<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 219

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!